BioSpace News Archive

Job Trends

New Life Science Spaces and Factories Under Construction and Opening

This week has marked a number of stories over construction projects and real estate developers focused on the life sciences market. Here’s a look.

July 19, 2019
·
3 min read
·
Mark Terry
Business

Could a ‘Bio-Belt’ Boost the Economy of Rural America?

For John Cumbers, chief executive officer of SynBioBeta, turning rural America into a biotech hotbed may be an answer to kick start the local economies and advance new products that could benefit the nation and world.

July 19, 2019
·
3 min read
·
Alex Keown
BioMidwest

AAIC Roundup: Alzheimer’s, Seizures, Sleep Medication, the LGBT Community and More

It was a big week for Alzheimer’s research as researchers from around the world descended on Los Angeles to attend the Alzheimer’s Association International Conference (AAIC) this week. Here’s a look at some of the stories you may have missed.

July 19, 2019
·
4 min read
·
Mark Terry
Policy

Martin Shkreli Loses Criminal Conviction Appeal

A three-judge panel ruled against Shkreli’s appeals team, claiming that the trial judge’s directions were clear and within the law.

July 19, 2019
·
2 min read
·
Alex Keown
BioForest

Losing the War on Antibiotic-Resistant Infections Because of Market Forces

There’s clearly a need for new antibiotics to fight infections. If so, why are so many companies in the space abandoning it or going out of business?

July 19, 2019
·
4 min read
·
Mark Terry
Business

First U.S. SMA Patient Already Treated with Zolgensma

Novartis Chief Executive Officer Vas Narasimhan is excited about the company’s progress through the first half of 2019 and expects that momentum to continue with a “catalyst-rich” second half of the year.

July 19, 2019
·
2 min read
·
Alex Keown
Pharm Country

Clinical Catch-up for July 15-19

Here’s a look at the top clinical trial news from last week, with updates from Neon, GSK, Biohaven, and more.

July 19, 2019
·
4 min read
·
Mark Terry
Business

Gilead Snaps up Antiviral Programs From Novartis, Follows Slew of Other Pipeline-Bolstering Deals

In addition to the three preclinical assets from Novartis, Gilead has recently entered into deals to develop therapies for HIV, RA and NASH.

July 19, 2019
·
2 min read
·
Alex Keown
Career Advice

The Top 3 Factors That Lead to Happiness at Work

Have you ever wondered why some life science professionals seem very happy at work, and appear to love their jobs? At the same time, their co-workers in an identical position are miserable.

July 19, 2019
·
3 min read
·
Porschia Parker
Business

Acacia Founder and ViiV’s Longtime CSO Are Planning to Step Down From Their Companies

Acacia’s founder will continue on in an advisory role while ViiV’s departing CSO is eying multiple opportunities.

July 19, 2019
·
2 min read
·
Alex Keown